Glasgow: The role of a specific protein in the development of prostate cancer
is being investigated by scientists at the University of Glasgow. Prof Baillie, of the Institute of Cardiovascular & Medical
Sciences, said: “We know that the amount of a protein called PDE4D7
significantly differs between hormone responsive and hormone
unresponsive prostate cancers. This protein binds to a number of other
proteins. “We want to investigate these links and see if we can use this
information to develop a new strategy to halt the growth of the cancer
cells. This will identify potential targets for new treatments for
advanced prostate cancer, and funding provided by Prostate Cancer UK and
Movember will allow us to take one step closer to this goal.”
Sarah Coghlan, UK Country Director at The Movember Foundation, said:
“It's through the efforts of 10,000 Mo Bros and Mo Sistas in Scotland,
and thousands more across the UK, that we have been able to fund such
vital research to address the key challenges in prostate cancer. With
continued support we can do more so that fewer men die from prostate
cancer - and those that live can enjoy happier, healthier, longer
lives.”
Dr Iain Frame, Director of Research at Prostate Cancer UK, said:
“Through our ongoing partnership with the Movember Foundation we have
been able to fund another bumper round of high quality research grants
this year. These focus on the key issues facing prostate cancer - from
identifying men at risk of developing aggressive forms to discovering
new treatments for advanced disease.
“However the story doesn’t end here. We really need more help to
build on the great work that is already underway if we are to accelerate
the process of conquering the most common cancer in men. As part of our
ongoing Men United campaign we are calling on people across the country
to make this summer count by doing something with their friends to
raise funds and help beat the disease. Prostate cancer takes 10,000
lives every year. By pulling together we can stop it in its tracks.”